Besides, the expression of signalling proteins p-β-catenin, β-catenin, AMPK and SIRT1 in each tumor were declined in both low and high dose groups in a different extent, compared to that of in solvent group (Fig. 5G). The gene discussed is SIRT1; the disease is neoplasm.